The Site of Origin of Medulloblastoma: Surgical Observations Correlated to Molecular Groups

Olga Ciobanu-Caraus1, Thomas Czech1, Andreas Peyrl2,3

  • 1Department of Neurosurgery, Medical University of Vienna, 1090 Vienna, Austria.

Cancers
|October 14, 2023
PubMed

Insights

Intraoperative site of origin (STO) assessment has limited predictive value for medulloblastoma (MB) molecular groups. While useful for SHH-MB and non-WNT/non-SHH MB, it is less accurate for WNT-MB prediction.

Area of Science:

  • Pediatric neuro-oncology
  • Developmental neurobiology
  • Surgical oncology

Background:

  • Medulloblastoma (MB) molecular subgroups (WNT, SHH, non-WNT/non-SHH) have distinct developmental origins.
  • WNT-MB is hypothesized to originate from the embryonic lower rhombic lip (LRL).
  • SHH-MB and other MB types are thought to arise from cerebellar precursor matrix regions.

Purpose of the Study:

  • To analyze intraoperative site of origin (STO) data in pediatric medulloblastoma.
  • To compare the intraoperatively determined STO with hypothesized embryological regions of origin for MB molecular groups.
  • To evaluate the predictive value of neurosurgical inspection for MB molecular classification.

Main Methods:

  • Retrospective review of 58 pediatric MB cases operated between 1996 and 2020.
  • Analysis of detailed operative reports, surgical videos, and clinical/genetic data.
  • Assessment of STO based on intraoperative neurosurgical findings.

Main Results:

  • The intraoperatively assessed STO correctly predicted molecular groups in 20% of WNT-MB, 60% of SHH-MB, and 71% of non-WNT/non-SHH MB.
  • Positive predictive values for STO were 0.21 for WNT-MB, 0.86 for SHH-MB, and 0.73 for non-WNT/non-SHH MB.
  • Neurosurgical inspection showed limited accuracy in predicting the molecular group of medulloblastoma.

Conclusions:

  • The intraoperatively observed STO has a limited predictive value for determining the molecular group of medulloblastoma.
  • Accurate molecular subtyping of MB may require methods beyond intraoperative surgical assessment.
  • Further research is needed to refine methods for predicting MB molecular groups during surgery.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.0K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K